The coronavirus emergency relief bill that went into effect in March will include money earmarked for the U.S. Food and Drug Administration (FDA) to help respond to the coronavirus.
The $2 trillion coronavirus aid bill includes $80 million for the FDA to continue its COVID-19 efforts, which include "the development of medical countermeasures and vaccines, promoting the advanced manufacturing of medical products and monitoring of the medical product supply chain," according to a press release from the FDA.
The $80 million is in addition to the $61 million the FDA received from earlier coronavirus legislation bill.
Also involved in the bill is a change in how the FDA regulates over-the-counter (OTC) drugs. The new legislation will help the FDA to modernize its OTC drug development and review process.